Variable | No adverse group (n = 171) | Adverse group (n = 37) | t | P |
---|---|---|---|---|
Age(years) | 66.75 ± 9.93 | 71.74 ± 9.06 | 2.813 | 0.005 |
Sex (m/f) | 92 (53.80)/79 (46.20) | 26 (70.27)/11 (29.73) | 3.361 | 0.067 |
Systolic blood pressure (mmHg) | 139.41 ± 15.41 | 143.95 ± 16.77 | 1.599 | 0.111 |
Heart rate (beats/min) | 70.74 ± 16.79 | 77.41 ± 15.82 | 2.191 | 0.030 |
Heart failure | 99 (57.89) | 31 (83.78) | 8.699 | 0.003 |
Diabetes | 35 (20.47) | 8 (21.62) | 0.025 | 0.875 |
High blood pressure | 47 (27.49) | 9 (24.32) | 0.155 | 0.694 |
hs-TnT (ug/L) | 30.98 ± 4.51 | 35.61 ± 6.71 | 5.143 | < 0.001 |
NT-proBNP (ng/L) | 245.81 ± 73.96 | 312.93 ± 88.67 | 4.824 | < 0.001 |
D -dimer (ng/mL) | 596.94 ± 141.01 | 643.59 ± 157.10 | 1.787 | 0.075 |
CK (U/L) | 12.1 (7.4, 18.2) | 13.5 (8.8, 23.8) | 1.634 | 0.096 |
CK-MB (U/L) | 10.7 (5.2, 15.6) | 11.2 (6.3, 16.9) | 1.212 | 0.147 |
Creatinine (umol/L) | 67.89 ± 6.36 | 69.15 ± 7.33 | 1.063 | 0.289 |
ALT (U/L) | 34.36 ± 8.12 | 35.39 ± 6.78 | 0.719 | 0.473 |
AST (U/L) | 19.57 ± 4.12 | 21.01 ± 5.35 | 1.822 | 0.070 |
Hemoglobin (g/L) | 135.36 ± 14.41 | 131.95 ± 15.63 | 1.285 | 0.200 |
Hematocrit value (%) | 38.99 ± 2.61 | 38.12 ± 2.04 | 1.904 | 0.058 |
LVEF (%) | 47.52 ± 3.60 | 68.71 ± 3.92 | 1.794 | 0.074 |
TC (mmol/L) | 4.74 ± 0.69 | 4.91 ± 1.24 | 1.153 | 0.250 |
TG (mmol/L) | 2.51 ± 1.03 | 2.73 ± 1.09 | 1.166 | 0.245 |
QTC > 450 ms | 100 (58.48) | 29 (78.38) | 5.113 | 0.024 |